Download image:
919-541-7276

Jenny L. Wiley

Senior Fellow, Behavioral Pharmacology

Jenny Wiley, PhD, is a leading expert in behavioral pharmacology who has worked extensively with various multidisciplinary and multi-institutional teams focused on studies that use a wide range of methods from molecular to behavioral.

Dr. Wiley designs and supervises a program of in vivo research that complements existing strengths of the Center for Discovery and Analytical Sciences, including the synthesis and development of candidate medications and investigation of neural mechanisms underlying substance abuse. She also conducts independent National Institutes of Health grant-supported research in the area of cannabinoid pharmacology, an area in which she has an extensive record of peer-reviewed publications.

Before joining RTI in March 2010, Dr. Wiley was a professor in the Department of Pharmacology and Toxicology at VCU, where she still maintains an affiliate appointment. Additionally, she has been involved in governance of the International Cannabinoid Research Society for many years and served as the Society’s president at the 2013 meeting.

Education

Postdoctoral Fellowship, Pharmacology, Virginia Commonwealth University; PhD, Biological Psychology, Virginia Commonwealth University; MS, Biological Psychology, Virginia Commonwealth University; BS, Psychology (minor: English), College of William and Mary.

Latest Publications

Wiley, J.L., Lefever, T.W., Cortes, R.A., & Marusich, J.A. (2014). Cross-Substitution of Delta9-Tetrahydrocannabinol and JWH-018 in Drug Discrimination in Rats. Pharmacology, Biochemistry, and Behavior, 124 :123-128.
Wiley, J.L., Walentiny, D.M., Wright, M.J., Beardsley, P.M., Burston, J.J., Poklis, J.L., et al. (2014). Endocannabinoid contribution to Delta9-tetrahydrocannabinol discrimination in rodents. European Journal of Pharmacology, 737 :97-105.
Marusich, J.A., Lefever, T.W., Antonazzo, K.R., Craft, R.M., & Wiley, J.L. (2014). Evaluation of sex differences in cannabinoid dependence. Drug and Alcohol Dependence, 137 :20-28.
Gamage, T.F., Ignatowska-Jankowska, B.M., Wiley, J.L., Abdelrahman, M., Trembleau, L., Greig, I.R., et al. (2014). In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. Biochemical Pharmacology, 25 (2):182-185.
View all publications by Jenny L. Wiley (158)

Expertise

  • Cannabinoid Pharmacology
  • Behavioral Pharmacology
  • Neuropharmacology
  • Animal Models of Substance Abuse